Oui, les femmes en âge de procréer sont plus susceptibles de souffrir de carence en fer.
Carence en ferFemmesÂge de procréer
#4
Les sportifs sont-ils à risque ?
Oui, les athlètes peuvent avoir un risque accru de carence en fer en raison de l'effort physique.
SportifsCarence en ferEffort physique
#5
Les maladies chroniques augmentent-elles le risque ?
Oui, des maladies comme l'insuffisance rénale peuvent augmenter le risque de troubles du fer.
Maladies chroniquesInsuffisance rénaleTroubles du fer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles du métabolisme du fer : Questions médicales les plus fréquentes",
"headline": "Troubles du métabolisme du fer : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles du métabolisme du fer : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2026-06-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles du métabolisme du fer"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies métaboliques",
"url": "https://questionsmedicales.fr/mesh/D008659",
"about": {
"@type": "MedicalCondition",
"name": "Maladies métaboliques",
"code": {
"@type": "MedicalCode",
"code": "D008659",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hyperferritinémie",
"alternateName": "Hyperferritinemia",
"url": "https://questionsmedicales.fr/mesh/D000085583",
"about": {
"@type": "MedicalCondition",
"name": "Hyperferritinémie",
"code": {
"@type": "MedicalCode",
"code": "D000085583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carences en fer",
"alternateName": "Iron Deficiencies",
"url": "https://questionsmedicales.fr/mesh/D000090463",
"about": {
"@type": "MedicalCondition",
"name": "Carences en fer",
"code": {
"@type": "MedicalCode",
"code": "D000090463",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie par carence en fer",
"alternateName": "Anemia, Iron-Deficiency",
"url": "https://questionsmedicales.fr/mesh/D018798",
"about": {
"@type": "MedicalCondition",
"name": "Anémie par carence en fer",
"code": {
"@type": "MedicalCode",
"code": "D018798",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Surcharge en fer",
"alternateName": "Iron Overload",
"url": "https://questionsmedicales.fr/mesh/D019190",
"about": {
"@type": "MedicalCondition",
"name": "Surcharge en fer",
"code": {
"@type": "MedicalCode",
"code": "D019190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémosidérose",
"alternateName": "Hemosiderosis",
"url": "https://questionsmedicales.fr/mesh/D006486",
"about": {
"@type": "MedicalCondition",
"name": "Hémosidérose",
"code": {
"@type": "MedicalCode",
"code": "D006486",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565.500.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles du métabolisme du fer",
"alternateName": "Iron Metabolism Disorders",
"code": {
"@type": "MedicalCode",
"code": "D019189",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan-Zhong Chang",
"url": "https://questionsmedicales.fr/author/Yan-Zhong%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Molecular Iron Metabolism, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei Province, China. chang7676@163.com."
}
},
{
"@type": "Person",
"name": "Elena Buzzetti",
"url": "https://questionsmedicales.fr/author/Elena%20Buzzetti",
"affiliation": {
"@type": "Organization",
"name": "Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy."
}
},
{
"@type": "Person",
"name": "Elena Corradini",
"url": "https://questionsmedicales.fr/author/Elena%20Corradini",
"affiliation": {
"@type": "Organization",
"name": "Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy."
}
},
{
"@type": "Person",
"name": "Sijin Liu",
"url": "https://questionsmedicales.fr/author/Sijin%20Liu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China."
}
},
{
"@type": "Person",
"name": "Yi Liu",
"url": "https://questionsmedicales.fr/author/Yi%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The influence of iron on bone metabolism disorders.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37857915",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00198-023-06937-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Iron metabolism disorder and multiple sclerosis: a comprehensive analysis.",
"datePublished": "2024-03-21",
"url": "https://questionsmedicales.fr/article/38590521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1376838"
}
},
{
"@type": "ScholarlyArticle",
"name": "Iron metabolism in autism spectrum disorder; inference through single nucleotide polymorphisms in key iron metabolism genes.",
"datePublished": "2023-09-25",
"url": "https://questionsmedicales.fr/article/37813049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jns.2023.120817"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dietary Iron Overload Triggers Hepatic Metabolic Disorders and Inflammation in Laying Hen.",
"datePublished": "2024-03-19",
"url": "https://questionsmedicales.fr/article/38502261",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12011-024-04149-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Immune Infiltration and Iron Metabolism-Related Subgroups in Autism Spectrum Disorder.",
"datePublished": "2024-01-18",
"url": "https://questionsmedicales.fr/article/38236354",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12031-023-02179-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles du métabolisme du fer",
"item": "https://questionsmedicales.fr/mesh/D019189"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles du métabolisme du fer - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles du métabolisme du fer",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles du métabolisme du fer",
"description": "Comment diagnostiquer une carence en fer ?\nQuels tests pour l'hémochromatose ?\nQuels signes indiquent un trouble du métabolisme du fer ?\nL'IRM peut-elle aider au diagnostic ?\nQuand faire un bilan du fer ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles du métabolisme du fer",
"description": "Quels sont les symptômes d'une surcharge en fer ?\nComment se manifeste une carence en fer ?\nY a-t-il des symptômes digestifs ?\nLes troubles du métabolisme du fer affectent-ils la peau ?\nPeut-on avoir des troubles cognitifs ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles du métabolisme du fer",
"description": "Comment prévenir une carence en fer ?\nLes femmes enceintes doivent-elles se supplémenter ?\nQuels aliments sont riches en fer ?\nLe thé affecte-t-il l'absorption du fer ?\nLes enfants ont-ils besoin de fer ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles du métabolisme du fer",
"description": "Comment traiter une carence en fer ?\nQuels médicaments pour l'hémochromatose ?\nLes transfusions sont-elles nécessaires ?\nY a-t-il des traitements naturels ?\nComment surveiller le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles du métabolisme du fer",
"description": "Quelles complications peuvent survenir avec une surcharge en fer ?\nUne carence en fer peut-elle causer des complications ?\nLes troubles du métabolisme du fer affectent-ils la grossesse ?\nY a-t-il des risques pour le cœur ?\nLes troubles du métabolisme du fer peuvent-ils affecter le diabète ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles du métabolisme du fer",
"description": "Qui est à risque de carence en fer ?\nQuels facteurs augmentent le risque d'hémochromatose ?\nLe sexe influence-t-il le risque de carence ?\nLes sportifs sont-ils à risque ?\nLes maladies chroniques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D019189#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en fer ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage de la ferritine et du fer sérique, ainsi qu'une numération globulaire, sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels tests pour l'hémochromatose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test génétique et un dosage de la transferrine sont souvent réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un trouble du métabolisme du fer ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, pâleur, douleurs abdominales et anomalies des tests sanguins peuvent indiquer un trouble."
}
},
{
"@type": "Question",
"name": "L'IRM peut-elle aider au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM peut évaluer la surcharge en fer dans les organes, notamment le foie."
}
},
{
"@type": "Question",
"name": "Quand faire un bilan du fer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bilan est recommandé en cas de symptômes d'anémie ou de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surcharge en fer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs articulaires, et troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une carence en fer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par fatigue, faiblesse, essoufflement et pâleur de la peau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales, des nausées et des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles du métabolisme du fer affectent-ils la peau ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de couleur de la peau et des ongles peuvent être observés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles cognitifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la concentration et de la mémoire peuvent être liés à une carence en fer."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en fer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fer, comme les viandes rouges et les légumes verts, est essentielle."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se supplémenter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent souvent prendre des suppléments de fer pour prévenir les carences."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en fer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lentilles, les épinards, et les viandes rouges sont de bonnes sources de fer."
}
},
{
"@type": "Question",
"name": "Le thé affecte-t-il l'absorption du fer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le thé peut inhiber l'absorption du fer, surtout s'il est consommé avec les repas."
}
},
{
"@type": "Question",
"name": "Les enfants ont-ils besoin de fer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants en croissance ont besoin de fer pour un développement sain."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en fer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de fer et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour l'hémochromatose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents chélateurs du fer et des saignées thérapeutiques sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Les transfusions sont-elles nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être nécessaires en cas d'anémie sévère ou de surcharge en fer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes comme l'ortie peuvent aider, mais consultez un médecin d'abord."
}
},
{
"@type": "Question",
"name": "Comment surveiller le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers des niveaux de fer et de ferritine sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une surcharge en fer ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies du foie, des troubles cardiaques et du diabète."
}
},
{
"@type": "Question",
"name": "Une carence en fer peut-elle causer des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications comme l'anémie ferriprive et des problèmes cognitifs."
}
},
{
"@type": "Question",
"name": "Les troubles du métabolisme du fer affectent-ils la grossesse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des complications comme un faible poids à la naissance."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour le cœur ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surcharge en fer peut augmenter le risque de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles du métabolisme du fer peuvent-ils affecter le diabète ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent influencer la résistance à l'insuline et aggraver le diabète."
}
},
{
"@type": "Question",
"name": "Qui est à risque de carence en fer ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes enceintes, les végétariens et les personnes ayant des pertes sanguines fréquentes sont à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hémochromatose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux et des maladies hépatiques augmentent le risque d'hémochromatose."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de carence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes en âge de procréer sont plus susceptibles de souffrir de carence en fer."
}
},
{
"@type": "Question",
"name": "Les sportifs sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent avoir un risque accru de carence en fer en raison de l'effort physique."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'insuffisance rénale peuvent augmenter le risque de troubles du fer."
}
}
]
}
]
}
Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy.
Department of Medical and Surgical Science for Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Publications dans "Troubles du métabolisme du fer" :
Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy.
Department of Medical and Surgical Science for Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Publications dans "Troubles du métabolisme du fer" :
State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Publications dans "Troubles du métabolisme du fer" :
Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Publications dans "Troubles du métabolisme du fer" :
School of Life Sciences, Northwestern Polytechnical University, Xi'an, China.
Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environment Biophysics, Northwestern Polytechnical University, Xi'an, China.
Department of Spinal Surgery, People's Hospital of Longhua, Affiliated Hospital of Southern Medical University, Shenzhen, China.
Publications dans "Troubles du métabolisme du fer" :
Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environment Biophysics, Northwestern Polytechnical University, Xi'an, China.
Publications dans "Troubles du métabolisme du fer" :
Department of Nutritional Sciences, School of Life Course Sciences, King's College London, Franklin-Wilkins-Building, 150 Stamford Street, London SE1 9NH, UK. yemisi.latunde-dada@kcl.ac.uk.
Publications dans "Troubles du métabolisme du fer" :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023-10-19
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023-10-19
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023-10-19
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023-10-19
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023-10-19
Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy.
Department of Medical and Surgical Science for Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Publications dans "Troubles du métabolisme du fer" :
Regional Reference Centre for Diagnosing and Management of Porphyrias, Internal Medicine Unit and Centre for Hemochromatosis and Hereditary Liver Diseases, ERN-EuroBloodNet Centre for Iron Disorders, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41124 Modena, Italy.
Department of Medical and Surgical Science for Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Publications dans "Troubles du métabolisme du fer" :
Iron is a necessary trace element in the human body, and it participates in many physiological processes. Disorders of iron metabolism can cause lesions in many tissues and organs, including bone. Rec...
Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system. Currently, the pathological mechanisms of MS are not fully understood, but research has suggested...
The study utilized publicly available databases and bioinformatics techniques for gene expression data analysis, including differential expression analysis, weighted correlation network analysis, gene...
This study identified IREB2, LAMP2, ISCU, ATP6V1G1, ATP13A2, and SKP1 as genes associated with multiple sclerosis (MS) and iron metabolism, establishing their multi-gene diagnostic value for MS with a...
This study comprehensively explored the relationship between iron metabolism and MS through integrated bioinformatics analysis and Mendelian randomization methods. The findings provide important insig...
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental problems with various genetic and environmental components. The ASD diagnosis is based on symptom expression without relia...
Iron, an essential trace element, is involved in various physiological processes; however, consumption of excessive iron possesses detrimental effects. In practical feed production, the iron content a...
Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with a broad spectrum of symptoms and prognoses. Effective therapy requires understanding this variability. ASD children's cog...
Iron overload is closely associated with metabolic dysfunction. However, the role of iron in the hypothalamus remains unclear. Here, we find that hypothalamic iron levels are increased, particularly i...
Leukemia inhibitory factor (LIF) is a multifunctional cytokine that plays a crucial role in various biological processes. However, LIF involvement in iron metabolism remains almost unexplored. This st...
Iron deficiency and iron-related disorders are common health issues worldwide, affecting a significant proportion of the population. Diagnosis and management of these disorders rely heavily on using v...
This review article provides an overview of the most commonly used iron-related biomarkers, including serum ferritin, transferrin saturation, soluble transferrin receptor, zinc protoporphyrin, and fre...
Iron plays a vital role in various physiological processes, including oxygen transport, energy metabolism, and DNA synthesis. The article highlights the advantages and limitations of iron biomarkers a...
Using iron-related biomarkers in screening and monitoring programs can improve patient outcomes and reduce healthcare costs....
SASI (single anastomosis sleeve ileal) bypass can lead to nutritional deficiencies, including disorders of iron metabolism and anemia. This study aims to evaluate the effect of SASI bypass on weight l...
This study is a retrospective analysis of prospectively collected data from patients who underwent SASI bypass at our hospital between January 2020 and February 2022....
The mean age of the patients was 42 years (range 22-58). The average duration of the follow-up period was 26 months. The mean percentage of excess weight loss (%EWL) was 90.1%, and total weight loss (...
SASI bypass is an effective bariatric procedure in weight loss outcomes. However, there may be an increased risk of anemia and iron metabolism disruptions associated with this procedure. The common li...
Studies in patients with heart failure have indicated that sodium-glucose cotransporter 2 (SGLT2) inhibitors increase iron use and enhance erythropoiesis. In this post-hoc analysis of the CREDENCE tri...
We measured serum iron, total iron binding capacity (TIBC), transferrin saturation (TSAT) and ferritin at baseline and 12 months. The effects of canagliflozin, relative to placebo, on iron markers wer...
Of 4401 participants randomized in CREDENCE, 2416 (54.9%) had iron markers measured at baseline, of whom 924 (38.2%) were iron deficient. Canagliflozin, compared to placebo, increased TIBC by 2.1% (95...
Iron deficiency is highly prevalent in patients with type 2 diabetes and CKD. Canagliflozin increased TIBC and decreased ferritin in patients with T2D and CKD, suggesting increased iron utilization, a...